S&P 500   4,577.11 (-1.84%)
DOW   35,368.47 (-1.51%)
QQQ   370.55 (-2.49%)
AAPL   169.80 (-1.89%)
MSFT   302.65 (-2.43%)
FB   318.15 (-4.14%)
GOOGL   2,719.96 (-2.50%)
AMZN   3,178.35 (-1.99%)
TSLA   1,030.51 (-1.82%)
NVDA   259.03 (-3.86%)
BABA   128.60 (-2.26%)
NIO   29.61 (-4.33%)
AMD   131.93 (-3.62%)
CGC   7.78 (-7.38%)
MU   92.87 (-4.61%)
GE   102.89 (-0.26%)
T   27.31 (+0.48%)
F   24.38 (-3.22%)
DIS   152.27 (+0.22%)
AMC   18.84 (-8.41%)
PFE   54.11 (-1.53%)
ACB   5.11 (-7.26%)
BA   225.01 (-0.42%)
S&P 500   4,577.11 (-1.84%)
DOW   35,368.47 (-1.51%)
QQQ   370.55 (-2.49%)
AAPL   169.80 (-1.89%)
MSFT   302.65 (-2.43%)
FB   318.15 (-4.14%)
GOOGL   2,719.96 (-2.50%)
AMZN   3,178.35 (-1.99%)
TSLA   1,030.51 (-1.82%)
NVDA   259.03 (-3.86%)
BABA   128.60 (-2.26%)
NIO   29.61 (-4.33%)
AMD   131.93 (-3.62%)
CGC   7.78 (-7.38%)
MU   92.87 (-4.61%)
GE   102.89 (-0.26%)
T   27.31 (+0.48%)
F   24.38 (-3.22%)
DIS   152.27 (+0.22%)
AMC   18.84 (-8.41%)
PFE   54.11 (-1.53%)
ACB   5.11 (-7.26%)
BA   225.01 (-0.42%)
S&P 500   4,577.11 (-1.84%)
DOW   35,368.47 (-1.51%)
QQQ   370.55 (-2.49%)
AAPL   169.80 (-1.89%)
MSFT   302.65 (-2.43%)
FB   318.15 (-4.14%)
GOOGL   2,719.96 (-2.50%)
AMZN   3,178.35 (-1.99%)
TSLA   1,030.51 (-1.82%)
NVDA   259.03 (-3.86%)
BABA   128.60 (-2.26%)
NIO   29.61 (-4.33%)
AMD   131.93 (-3.62%)
CGC   7.78 (-7.38%)
MU   92.87 (-4.61%)
GE   102.89 (-0.26%)
T   27.31 (+0.48%)
F   24.38 (-3.22%)
DIS   152.27 (+0.22%)
AMC   18.84 (-8.41%)
PFE   54.11 (-1.53%)
ACB   5.11 (-7.26%)
BA   225.01 (-0.42%)
S&P 500   4,577.11 (-1.84%)
DOW   35,368.47 (-1.51%)
QQQ   370.55 (-2.49%)
AAPL   169.80 (-1.89%)
MSFT   302.65 (-2.43%)
FB   318.15 (-4.14%)
GOOGL   2,719.96 (-2.50%)
AMZN   3,178.35 (-1.99%)
TSLA   1,030.51 (-1.82%)
NVDA   259.03 (-3.86%)
BABA   128.60 (-2.26%)
NIO   29.61 (-4.33%)
AMD   131.93 (-3.62%)
CGC   7.78 (-7.38%)
MU   92.87 (-4.61%)
GE   102.89 (-0.26%)
T   27.31 (+0.48%)
F   24.38 (-3.22%)
DIS   152.27 (+0.22%)
AMC   18.84 (-8.41%)
PFE   54.11 (-1.53%)
ACB   5.11 (-7.26%)
BA   225.01 (-0.42%)
NYSE:RE

Everest Re Group Price Target, Predictions & Analyst Ratings

$290.90
+0.60 (+0.21%)
(As of 01/18/2022 12:00 AM ET)
Add
Compare
Today's Range
$288.96
$293.65
50-Day Range
$256.38
$290.30
52-Week Range
$209.63
$293.65
Volume
310,630 shs
Average Volume
202,594 shs
Market Capitalization
$11.54 billion
P/E Ratio
11.55
Dividend Yield
2.14%
Beta
0.69

Everest Re Group (NYSE:RE) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analyst Rating Consensus

Buy
Based on 5 Analyst Ratings

Analyst Price Target Consensus

$317.60
9.18% Upside

High PT$335.00
Average PT$317.60
Low PT$287.00
TypeCurrent
1/18/21 to 1/18/22
1 Month Ago
12/19/20 to 12/19/21
3 Months Ago
10/20/20 to 10/20/21
1 Year Ago
1/19/20 to 1/18/21
Consensus Rating
Buy
Buy
Buy
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
4 Buy rating(s)
4 Buy rating(s)
4 Buy rating(s)
4 Buy rating(s)
Hold
1 Hold rating(s)
1 Hold rating(s)
2 Hold rating(s)
6 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$317.60$315.60$292.17$261.40
Price Target Upside9.18% Upside18.55% Upside15.97% Upside18.30% Upside
Get Everest Re Group Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for RE and its competitors with MarketBeat's FREE daily newsletter.


Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Everest Re Group (NYSE:RE) vs. Its Competitors

TypeEverest Re GroupFinance CompaniesS&P 500
Consensus Rating Score
2.80
2.52
2.55
Consensus RatingBuyBuyBuy
Price Target Upside9.18% Upside29.07% Upside12.74% Upside
News Sentiment RatingPositive News
Neutral News
Neutral News
MarketBeat
Community Rating
Outperform Votes
312
52.44%
Underperform Votes
283
47.56%
Avg. Outperform Votes
197
62.54%
Avg. Underperform Votes
118
37.46%
Avg. Outperform Votes
837
69.40%
Avg. Underperform Votes
369
30.60%

Everest Re Group (NYSE:RE) Analyst Ratings History

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
1/14/2022Morgan Stanley
Boost Price TargetOverweight$321.00 ➝ $331.00+15.64%
11/18/2021Jefferies Financial Group
Initiated CoverageBuy$335.00+22.08%
8/16/2021Wolfe Research
Initiated CoverageOutperform$330.00+21.47%
6/18/2021Citigroup
DowngradeBuy ➝ Neutral
3/28/2021Deutsche Bank Aktiengesellschaft
UpgradeHold ➝ Buy$245.00 ➝ $305.00+21.93%
12/8/2020Smith Barney Citigroup
UpgradeNeutral ➝ Buy$245.00 ➝ $275.00+19.40%
11/10/2020Credit Suisse Group
Boost Price TargetNeutral$218.00 ➝ $235.00+1.43%
8/10/2020UBS Group
Boost Price TargetNeutral$235.00 ➝ $246.00+5.53%
7/6/2020Bank of America
Initiated CoverageBuy$258.00+28.39%
6/16/2020Wells Fargo & Company
UpgradeEqual Weight ➝ Overweight$203.00 ➝ $255.00+18.63%
4/2/2020Keefe, Bruyette & Woods
UpgradeMarket Perform ➝ Outperform$263.00+45.11%
2/12/2020Cfra
Boost Price TargetHold$272.00 ➝ $305.00+4.58%
1/7/2020Barclays
Jay Gelb
Reiterated RatingBuy$325.00+17.50%
(Data available from 1/18/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)












Everest Re Group (NYSE:RE) Analyst Ratings Frequently Asked Questions

What is Everest Re Group's consensus rating and price target?

According to the issued ratings of 5 analysts in the last year, the consensus rating for Everest Re Group stock is Buy based on the current 1 hold rating and 4 buy ratings for RE. The average twelve-month price target for Everest Re Group is $317.60 with a high price target of $335.00 and a low price target of $287.00. Learn more on RE's analyst rating history

Do Wall Street analysts like Everest Re Group more than its competitors?

Analysts like Everest Re Group stock more than the stock of other Finance companies. The consensus rating score for Everest Re Group is 2.80 while the average consensus rating score for finance companies is 2.52. Learn more on how RE compares to other companies

Do MarketBeat users like Everest Re Group more than its competitors?

MarketBeat users like Everest Re Group stock less than the stock of other Finance companies. 52.44% of MarketBeat users gave Everest Re Group an outperform vote while finance companies recieve an average of 62.54% outperform votes by MarketBeat users.

Does Everest Re Group's stock price have much upside?

According to analysts, Everest Re Group's stock has a predicted upside of 18.47% based on their 12-month price targets.

What analysts cover Everest Re Group?

Everest Re Group has been rated by Jefferies Financial Group, and Morgan Stanley in the past 90 days.

This page was last updated on 1/18/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected]com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.